BOXED WARNING Do not administer intravenously or by other parenteral routes — deaths and serious/life-threatening events have occurred when capsule contents were injected parenterally.
Hepatic Reduce to 30 mg q4h in cirrhosis/severe hepatic impairment with close BP and HR monitoring
60 mg every 4 hours for 21 consecutive days
Instructions
Oral use only — never IV or parenteral
Give at least 1 h before or 2 h after meals
Swallow whole; if unable, extract contents into an oral (non-Luer) syringe and give via NG/PEG tube, then flush with 30 mL normal saline; label syringe 'Not for IV Use'
Start as soon as possible within 96 h of SAH onset
Avoid grapefruit juice
Contraindications
Concomitant use with strong CYP3A4 inhibitors (e.g., clarithromycin, telithromycin, HIV protease inhibitors, ketoconazole, itraconazole, voriconazole, nefazodone) — risk of significant hypotension
Cautions
Hypotension
Avoid strong CYP3A4 inducers
Caution with potential to exacerbate heart failure or AV conduction
Adverse reactions
Decreased blood pressure
Headache
Edema
Diarrhea
Rash
Nausea
Pregnancy Category C; animal teratogenicity; use only if potential benefit justifies risk
Lactation Undefined
⚠ BOXED WARNING
Do not administer intravenously; death and cardiac arrest have occurred